AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

NASDAQ:SURFSurface Oncology Earnings Date, Estimates & History

$4.69
-0.12 (-2.49 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.62
Now: $4.69
$5.04
50-Day Range
$1.67
MA: $2.88
$5.95
52-Week Range
$1.15
Now: $4.69
$7.66
Volume989,825 shs
Average Volume1.23 million shs
Market Capitalization$132.83 million
P/E RatioN/A
Dividend YieldN/A
Beta2.09

Earnings

Surface Oncology (NASDAQ:SURF) Earnings Information

Surface Oncology last issued its earnings results on May 12th, 2020. The reported $0.74 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.31. The business had revenue of $38.59 million for the quarter, compared to analyst estimates of $38.59 million. Surface Oncology has generated ($1.97) earnings per share over the last year. Surface Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 5th, 2020 based off prior year's report dates.

Surface Oncology Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Surface Oncology (NASDAQ:SURF) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.96 EPS
Next Year EPS Consensus Estimate: $-2.2 EPS

Surface Oncology (NASDAQ SURF) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/5/2020
(Estimated)
       
5/12/20203/31/2020$0.43$0.74$0.74$38.59 million$38.59 millionN/A
3/10/202012/31/2019($0.58)($0.57)($0.57)$2.50 million$0.44 millionN/A
11/12/2019Q3($0.58)($0.61)($0.61)$2.50 million$0.34 millionN/A
8/7/2019Q2 2019($0.62)($0.64)($0.64)$2.50 million$0.14 millionN/A
5/9/20193/31/2019($0.46)($0.15)($0.15)$2.50 million$14.43 millionN/A
3/7/2019Q4($0.6730)($0.17)($0.17)$2.00 million$9.76 millionN/A
11/13/2018Q3 2018($0.68)($0.62)($0.62)$2.00 million$1.73 millionN/A
8/14/2018Q2 2018($0.76)($0.73)($0.73)$2.43 millionN/A
5/29/2018Q4 2018$1.05$1.05$45.50 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.